Dashyant Dhanak's Net Worth

$6.82 Million

Estimate Recalculated May 9, 2024 05:28PM EST

Who is Dashyant Dhanak?

Dashyant Dhanak has an estimated net worth of $6.82 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, and Deciphera Pharmaceuticals, Inc..

SEC CIK

Dashyant Dhanak's CIK is 0001760682

Past Insider Trading and Trends

2020 was Dashyant Dhanak's most active year for acquiring shares with 14 total transactions. Dashyant Dhanak's most active month to acquire stocks was the month of June. 2020 was Dashyant Dhanak's most active year for disposing of shares, totalling 19 transactions. Dashyant Dhanak's most active month to dispose stocks was the month of June. 2021 saw Dashyant Dhanak paying a total of $314,408.52 for 43,190 shares, this is the most they've acquired in one year. In 2023 Dashyant Dhanak cashed out on 12,156 shares for a total of $580,826.52, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INCYTE CORP (INCY) Snapshot price: $57.59

EVP & Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.82%
8.06K
—
—
58.97K
Jul 14
Form 4
-10.61%
-6.04K
$62.08
-$375,211.52
50.91K
Jul 3
Form 4
+6.93%
3.69K
$65.42
$241,596.06
56.96K
Feb 16
Form 4
-4.34%
-2.42K
$85.00
-$205,615.00
53.26K
Scheduled
Jan 26
Form 4
+9.82%
4.98K
—
—
55.68K
Jan 20
Form 4
-1.04%
-533.00
$82.36
-$43,897.88
50.7K
Dec 12
Form 4
+21.58%
9.09K
$79.25
-$172,844.25
51.23K
Jul 2 - Jul 5
Form 4
—
0
—
—
0
Jan 19
Form 4
+25.93%
8.68K
—
—
42.14K
Jan 1
Form 4
-1.57%
-533.00
$65.40
-$34,858.20
33.46K
Dec 10
Form 4
+8.75%
2.73K
—
—
34K
Nov 19
Form 4
-1.23%
-389.00
$68.67
-$26,712.63
31.26K
Scheduled
Oct 1
Form 4
-1.21%
-388.00
$76.71
-$29,763.48
31.65K
Scheduled
Sep 1
Form 4
-1.20%
-389.00
$77.49
-$30,143.61
32.04K
Scheduled
Aug 2
Form 4
+24.02%
6.28K
$83.58
-$131,471.34
32.43K
Jul 2
Form 4
-1.49%
-396.00
$84.09
-$33,299.64
26.15K
Scheduled
Jul 1
Form 4
—
0
$76.21
-$82,975.10
26.55K
Scheduled
Jun 10
Form 4
-1.47%
-395.00
$84.13
-$33,231.35
26.55K
Scheduled
Jun 1
Form 4
-1.45%
-396.00
$85.40
-$33,818.40
26.94K
Scheduled
May 3
Form 4
-1.43%
-396.00
$81.57
-$32,301.72
27.34K
Scheduled
Apr 1
Form 4
-1.40%
-395.00
$79.73
-$31,493.35
27.73K
Scheduled
Mar 1
Form 4
-1.38%
-395.00
$77.71
-$59,171.38
28.13K
Scheduled
Feb 1
Form 4
—
0
—
—
0
Jan 15
Form 4
-2.46%
-720.00
$82.05
-$59,076.00
28.52K
Dec 10
Form 4
+4.40%
1.23K
—
—
29.24K
Nov 16
Form 4
—
0
$75.30
-$18,979.75
28.01K
Scheduled
Nov 6
Form 4
—
0
$78.69
-$25,514.55
28.01K
Scheduled
Oct 6
Form 4
—
0
$77.18
-$22,602.72
28.01K
Scheduled
Sep 8
Form 4
—
0
$81.61
-$31,117.18
28.01K
Scheduled
Aug 6
Form 4
+9.45%
2.42K
$65.42
$158,250.98
28.01K
Jul 13
Form 4
+28.04%
5.6K
$85.97
-$152,093.55
25.59K
Scheduled
Jul 2 - Jul 6
Form 4
—
0
$78.65
-$25,418.45
19.99K
Scheduled
Jun 8
Form 4
—
0
$81.13
-$30,194.62
19.99K
Scheduled
May 6
Form 4
—
0
$75.21
-$75,265.52
19.99K
Scheduled
Apr 6
Form 4
+52.50%
6.88K
—
—
19.99K
Feb 13
Form 4
—
0
—
—
0
Jan 17
Form 4
-3.91%
-533.00
$95.72
-$51,018.76
13.11K
Dec 10
Form 4
+98.30%
6.76K
—
—
13.64K
Jul 2
Form 4
∞
6.88K
—
—
6.88K
Dec 10
Form 3
—
0
—
—
0
No matching records found

Deciphera Pharmaceuticals, Inc. (DCPH) Snapshot price: $14

EVP & Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.26%
17.27K
—
—
158.18K
Feb 15
Form 4
∞
140.9K
—
—
140.9K
Sep 15
Form 3
—
0
—
—
0
No matching records found